Amgen’s Tavneos Under Scrutiny as Drug Linked to Deaths in Japan Sparks Global Safety Concerns
West Wood blvd – 16 May 2026 | Regulators in Japan have issued a stark warning after a recent safety notice identified a troubling pattern of severe liver injuries associated with the drug Tavneos, a medication marketed for a rare autoimmune condition. The notice, released by Kissei Pharmaceutical on May 15, highlighted that approximately 20 … Read more